Home > Products > CD55 & HLA-A
> Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (scFv4-Ig)
Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (scFv4-Ig) (CAT#: FVTIG-124)
Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (scFv4-Ig) is an appended IgG format, which includes four scFv moieties at the N-termini of the constant regions. It is a bivalent homodimer, in which one anti-CD55 scFv is fused to the CH1 domain of a heavy chain and another anti-HLA-A scFv to the CL domain of a light chain, or vice versa. The resulting leads to 2+2 antigen-binding valency. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.
HLA-A; major histocompatibility complex, class I, A; HLAA; HLA class I histocompatibility antigen, A-1 alpha chain; antigen presenting molecule; leukocyte antigen class I-A; MHC class I antigen HLA-A heavy chain
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
There are currently no customer reviews or questions for Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (scFv4-Ig) (FVTIG-124). Click the button below to contact us or submit your feedback about this product.